Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

319.48
-1.4800-0.46%
Volume:158.42K
Turnover:50.56M
Market Cap:19.23B
PE:34.68
High:320.00
Open:319.30
Low:317.21
Close:320.96
52wk High:330.75
52wk Low:249.57
Shares:60.18M
Float Shares:60.18M
Volume Ratio:0.95
T/O Rate:0.26%
Dividend:4.72
Dividend Rate:1.48%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.97
PE(LYR):7.70

Loading ...

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

GlobeNewswire
·
Aug 28

Venture Life Adds to Treasury Stock Under Share Buyback Programme

TIPRANKS
·
Aug 28

Echo IQ Loss Widens as Revenue Falls and Asset Base Shrinks

TIPRANKS
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Adheris Health Sets Date for FY26 Results and Investor Webinar

TIPRANKS
·
Aug 28

Integral Diagnostics Issues New Shares on Option Conversion

TIPRANKS
·
Aug 28

Envoy Medical Appoints Robert Potashnick Chief Accounting Officer, VP Finance

Reuters
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Aug 28

UnitedHealth downgraded to Hold from Buy at Erste Group

TIPRANKS
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

Globus Medical Acquires Higgs Boson Health

MT Newswires Live
·
Aug 27

Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone

Deep News
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

USP Group’s SII seals Kimera Health joint venture to push clean air and calibration into Southeast Asian healthcare

TIPRANKS
·
Aug 27